Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

Sansure Biotech’s “Full Scenario Solution” Appeared at MEDICA 2021, With Global Partners Gathered at the Booth
2021-11-23

From November 15-18, MEDICA was held in Düsseldorf, Germany. As the world’s largest medical industry event, MEDICA attracted thousands of companies from more than 60 countries and regions to exhibit their latest medical technologies and products. Sansure Biotech presented the full scenario solution for COVID-19, respiratory and reproductive tract infections at the exhibition. In Sansure’s booth, the “Fully Automated Solution” […]

LEARN MORE
Meet Sansure in Mexico!
2021-09-07

Sansure will be attending the “2021 Expo Med” . The international exhibition will be held from September 29th – October 1st in Mexico City (https://www.expomed.com.mx/en/home.html). If you would like to get more information about “Sansure Comprehensive COVID-19 diagnostic solutions”, “Sansure overall molecular diagnostic solutions” ,” and newly released molecular POCT devices, You are warmly welcome to visit our booth #3229 […]

LEARN MORE
1 4 5 6
×
Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.
SUBMIT

Thank you!

We shall contact you soon!
Back Top